Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Neurodegenerative Diseases

Translational Research of the Nervous System

Vol. 13, No. 2-3, 2014

Issue release date: January 2014

Alzheimer's and Parkinson's Diseases: Mechanisms, Clinical Strategies, and Promising Treatments of Neurodegenerative Diseases

11th International Conference AD/PD, Florence, March 2013: Proceedings

See also ISBN 978-3-318-02511-8 for more details
Add all to MyReading List
 
53

Title Page / Table of Contents

Neurodegener Dis 2014;13:53-56 (DOI:10.1159/000358281)
Free Access
57

Preface

Hanin I. · Nitsch R.M. · Windisch M. · Fisher A.
Neurodegener Dis 2014;13:57 (DOI:10.1159/000357825)
Free Access
58

Sustained Alzheimer's Amyloid Pathology in Myeloid Differentiation Protein-88-Deficient APPswe/PS1 Mice

Goll Y. · Bekenstein U. · Barbash S. · Greenberg D.S. · Zangen R. · Shoham S. · Soreq H.
Neurodegener Dis 2014;13:58-60 (DOI:10.1159/000353689)
 
61

Function and Dysfunction of Presenilin

Shen J.
Neurodegener Dis 2014;13:61-63 (DOI:10.1159/000354971)
Free Access
 
64

The E280A Presenilin Mutation Reduces Voltage-Gated Sodium Channel Levels in Neuronal Cells

Kim D.Y. · Wertz M.H. · Gautam V. · D'Avanzo C. · Bhattacharyya R. · Kovacs D.M.
Neurodegener Dis 2014;13:64-68 (DOI:10.1159/000354669)
69

Parkin Plays a Role in Sporadic Parkinson's Disease

Dawson T.M. · Dawson V.L.
Neurodegener Dis 2014;13:69-71 (DOI:10.1159/000354307)
72

ADAM10 in Synaptic Physiology and Pathology

Musardo S. · Marcello E. · Gardoni F. · Di Luca M.
Neurodegener Dis 2014;13:72-74 (DOI:10.1159/000354233)
75

Impact of Vitamin D on Amyloid Precursor Protein Processing and Amyloid-β Peptide Degradation in Alzheimer's Disease

Grimm M.O.W. · Lehmann J. · Mett J. · Zimmer V.C. · Grösgen S. · Stahlmann C.P. · Hundsdörfer B. · Haupenthal V.J. · Rothhaar T.L. · Herr C. · Bals R. · Grimm H.S. · Hartmann T.
Neurodegener Dis 2014;13:75-81 (DOI:10.1159/000355462)
82

Possible Role of Dynorphins in Alzheimer's Disease and Age-Related Cognitive Deficits

Ménard C. · Herzog H. · Schwarzer C. · Quirion R.
Neurodegener Dis 2014;13:82-85 (DOI:10.1159/000353848)
86

Hippocampus-Related Cognitive Impairments in Young apoE4 Targeted Replacement Mice

Salomon-Zimri S. · Boehm-Cagan A. · Liraz O. · Michaelson D.M.
Neurodegener Dis 2014;13:86-92 (DOI:10.1159/000354777)
93

Cytoskeletal Protection: Acting on Notch to Prevent Neuronal Dysfunction

Bonini S.A. · Ferrari-Toninelli G. · Maccarinelli G. · Bettinsoli P. · Montinaro M. · Memo M.
Neurodegener Dis 2014;13:93-95 (DOI:10.1159/000354230)
96

β-Amyloid Precursor Protein: Function in Stem Cell Development and Alzheimer's Disease Brain

Small D.H. · Hu Y. · Bolós M. · Dawkins E. · Foa L. · Young K.M.
Neurodegener Dis 2014;13:96-98 (DOI:10.1159/000353686)
99

The Therapeutic Effects of Human Adipose-Derived Stem Cells in Alzheimer's Disease Mouse Models

Chang K.-A. · Kim H.J. · Joo Y. · Ha S. · Suh Y.-H.
Neurodegener Dis 2014;13:99-102 (DOI:10.1159/000355261)
103

Tau Immunotherapy and Imaging

Sigurdsson E.M.
Neurodegener Dis 2014;13:103-106 (DOI:10.1159/000354491)
Free Access
107

Inhibition of Amyloid Precursor Protein Processing Leads to Downregulation of Apoptotic Genes in Alzheimer's Disease Animal Models

Rabinovich-Nikitin I. · Solomon B.
Neurodegener Dis 2014;13:107-109 (DOI:10.1159/000353749)
110

Regulation of Autophagy by LRRK2 in Caenorhabditis elegans

Saha S. · Liu-Yesucevitz L. · Wolozin B.
Neurodegener Dis 2014;13:110-113 (DOI:10.1159/000355654)
114

Defining the Native State of α-Synuclein

Selkoe D. · Dettmer U. · Luth E. · Kim N. · Newman A. · Bartels T.
Neurodegener Dis 2014;13:114-117 (DOI:10.1159/000355516)
118

Interplay between Parkin and p53 Governs a Physiological Homeostasis That Is Disrupted in Parkinson's Disease and Cerebral Cancer

Checler F. · Alves da Costa C.
Neurodegener Dis 2014;13:118-121 (DOI:10.1159/000354075)
122

Functional Interaction between Amyloid-β Precursor Protein and Peripherin Neurofilaments: A Shared Pathway Leading to Alzheimer's Disease and Amyotrophic Lateral Sclerosis?

Muresan V. · Villegas C. · Ladescu Muresan Z.
Neurodegener Dis 2014;13:122-125 (DOI:10.1159/000354238)
Free Access
126

Allelic Interference: A Mechanism for Trans-Dominant Transmission of Loss of Function in the Neurodegeneration of Familial Alzheimer's Disease

Robakis N.K. · Georgakopoulos A.
Neurodegener Dis 2014;13:126-130 (DOI:10.1159/000354241)
131

Employing Alzheimer Disease Animal Models for Translational Research: Focus on Dietary Components

Grossi C. · Ed Dami T. · Rigacci S. · Stefani M. · Luccarini I. · Casamenti F.
Neurodegener Dis 2014;13:131-134 (DOI:10.1159/000355461)
135

Stress Impairs Synaptic Plasticity in Triple-Transgenic Alzheimer's Disease Mice: Rescue by Ryanodine

Grigoryan G. · Biella G. · Albani D. · Forloni G. · Segal M.
Neurodegener Dis 2014;13:135-138 (DOI:10.1159/000354231)
139

Can the Calcium Hypothesis Explain Synaptic Loss in Alzheimer's Disease?

Popugaeva E. · Bezprozvanny I.
Neurodegener Dis 2014;13:139-141 (DOI:10.1159/000354778)
Free Access
142

The Inside-Out Amyloid Hypothesis and Synapse Pathology in Alzheimer's Disease

Gouras G.K. · Willén K. · Faideau M.
Neurodegener Dis 2014;13:142-146 (DOI:10.1159/000354776)
147

We Can Treat Alzheimer's Disease Successfully in Mice but Not in Men: Failure in Translation? A Perspective

Windisch M.
Neurodegener Dis 2014;13:147-150 (DOI:10.1159/000357568)
151

Prefibrillar Tau Oligomers in Mild Cognitive Impairment and Alzheimer's Disease

Mufson E.J. · Ward S. · Binder L.
Neurodegener Dis 2014;13:151-153 (DOI:10.1159/000353687)
Free Access
154

The Significance of α-Synuclein, Amyloid-β and Tau Pathologies in Parkinson's Disease Progression and Related Dementia

Compta Y. · Parkkinen L. · Kempster P. · Selikhova M. · Lashley T. · Holton J.L. · Lees A.J. · Revesz T.
Neurodegener Dis 2014;13:154-156 (DOI:10.1159/000354670)
157

Imaging and Cognitive Reserve Studies Predict Dementia in Presymptomatic Alzheimer's Disease Subjects

Ferrari C. · Nacmias B. · Bagnoli S. · Piaceri I. · Lombardi G. · Pradella S. · Tedde A. · Sorbi S.
Neurodegener Dis 2014;13:157-159 (DOI:10.1159/000353690)
160

Molecular Imaging in Sporadic Alzheimer's Disease Populations and Those Genetically at Risk

Nordberg A.
Neurodegener Dis 2014;13:160-162 (DOI:10.1159/000356333)
163

Imaging and Cerebrospinal Fluid Biomarkers in the Search for Alzheimer's Disease Mechanisms

Osorio R.S. · Pirraglia E. · Gumb T. · Mantua J. · Ayappa I. · Williams S. · Mosconi L. · Glodzik L. · de Leon M.J.
Neurodegener Dis 2014;13:163-165 (DOI:10.1159/000355063)
166

Relative Ratio and Level of Amyloid-β 42 Surrogate in Cerebrospinal Fluid of Familial Alzheimer Disease Patients with Presenilin 1 Mutations

Tagami S. · Okochi M. · Yanagida K. · Kodama T. · Arai T. · Kuwano R. · Ikeuchi T. · Takeda M.
Neurodegener Dis 2014;13:166-170 (DOI:10.1159/000355258)
171

The Neuroprotection Exerted by Memantine, Minocycline and Lithium, against Neurotoxicity of CSF from Patients with Amyotrophic Lateral Sclerosis, Is Antagonized by Riluzole

Yáñez M. · Matías-Guiu J. · Arranz-Tagarro J.-A. · Galán L. · Viña D. · Gómez-Pinedo U. · Vela Á. · Guerrero A. · Martínez-Vila E. · García A.G.
Neurodegener Dis 2014;13:171-179 (DOI:10.1159/000357281)
180

Familial Progressive Supranuclear Palsy: A Literature Review

Fujioka S. · Van Gerpen J.A. · Uitti R.J. · Dickson D.W. · Wszolek Z.K.
Neurodegener Dis 2014;13:180-182 (DOI:10.1159/000354975)
Free Access
183

Neuroinflammatory Phenotypes and Their Roles in Alzheimer's Disease

Wilcock D.M.
Neurodegener Dis 2014;13:183-185 (DOI:10.1159/000354228)
186

Resting-State Networks in Alzheimer's Disease and Parkinson's Disease

Rektorova I.
Neurodegener Dis 2014;13:186-188 (DOI:10.1159/000354237)
189

MRI for Iron Mapping in Alzheimer's Disease

Langkammer C. · Ropele S. · Pirpamer L. · Fazekas F. · Schmidt R.
Neurodegener Dis 2014;13:189-191 (DOI:10.1159/000353756)
192

Effect of Donepezil in Alzheimer Disease Can Be Measured by a Computerized Human Analog of the Morris Water Maze

Hort J. · Andel R. · Mokrisova I. · Gazova I. · Amlerova J. · Valis M. · Coulson E.J. · Harrison J. · Windisch M. · Laczó J.
Neurodegener Dis 2014;13:192-196 (DOI:10.1159/000355517)
197

How Can We Improve Transfer of Outcomes from Randomized Clinical Trials to Clinical Practice with Disease-Modifying Drugs in Alzheimer's Disease?

Gauthier S. · Leuzy A. · Rosa-Neto P.
Neurodegener Dis 2014;13:197-199 (DOI:10.1159/000353748)
200

Comparing Predictors of Conversion to Alzheimer's Disease Using the Disease State Index

Muñoz-Ruiz M.A. · Hall A. · Mattila J. · Koikkalainen J. · Herukka S.-K. · Vanninen R. · Liu Y. · Lötjönen J. · Soininen H. · Alzheimer's Disease Neuroimaging Initiative
Neurodegener Dis 2014;13:200-202 (DOI:10.1159/000354074)
203

Author Index Vol. 13, No. 2-3, 2014

Neurodegener Dis 2014;13:203 (DOI:10.1159/000358282)
Free Access
204

Subject Index Vol. 13, No. 2-3, 2014

Neurodegener Dis 2014;13:204 (DOI:10.1159/000358283)
Free Access